Sign In
Buy AXSM
$212.17
+1.13 (+0.535%)
At Close: Aug 04, 2026
Axsome Therapeutics Stock Rises 36% In A Month But Will The Rally Continue?
06:30am, Monday, 20'th Sep 2021
A couple of months back we discussed that Axsome Therapeutics stock is likely to rebound after it fell nearly 20% in a month following the U.S. FDA's decision to pull the breakthrough therapy designat
Axsome (AXSM) Begins Late-Stage Sleep Disorder Study on AXS-12
11:28am, Friday, 17'th Sep 2021
Axsome (AXSM) is developing AXS-12 as a potential treatment for narcolepsy. The company initiates enrollment in a phase III study evaluating AXS-12.
Axsome Therapeutics Initiates SYMPHONY Phase 3 Trial of AXS-12 in Narcolepsy
07:00am, Thursday, 16'th Sep 2021
NEW YORK, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorde
AXSM Stock: Why It Increased Today
08:48am, Tuesday, 14'th Sep 2021
The stock price of Axsome Therapeutics Inc (NASDAQ: AXSM) increased over 5% pre-market today. This is why it happened.
Axsome Therapeutics Inc Ranked Among Today's Top Shorts After The European Central Bank Says It May Slow Down Bond Purchases
10:43am, Thursday, 09'th Sep 2021
The Dow Jones dipped about 40 points, the S&P 500 was flat, and the Nasdaq saw some mild gains, led by Big Tech stocks such as Apple, Facebook, and Amazon. Find opportunities in today's market with th
Why Axsome Therapeutics Stock Cratered in August
02:15pm, Wednesday, 08'th Sep 2021
An unexpected regulatory setback weighed heavily on the biotech's shares last month.
Axsome (AXSM) Up 11.7% Since Last Earnings Report: Can It Continue?
01:16pm, Wednesday, 08'th Sep 2021
Axsome (AXSM) reported earnings 30 days ago. What's next for the stock?
3 Biotech Stocks Wall Street Expects to Double Soon
07:03am, Tuesday, 07'th Sep 2021
All three stocks on this list can more than double your money according to investment bank analysts who cover them.
Buy, Sell, or Hold Axsome Therapeutics Stock After Its FDA Approval Delay?
09:55am, Sunday, 05'th Sep 2021
There are still plenty of unknowns related to Axsome's FDA filing.
3 Biotech Stocks That Are Too Cheap to Ignore
06:02am, Thursday, 02'nd Sep 2021
You'll definitely want to check out these biotech bargains.
Here's Why Axsome Therapeutics Stock Is Surging Today
02:42pm, Wednesday, 01'st Sep 2021
The company still doesn't have much to say about the FDA and its experimental new anti-depression drug.
Which Biotech Stock Will Shock the Market in 2022?
10:40am, Friday, 27'th Aug 2021
Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022?
Axsome's (AXSM) Stock Up Despite FDA Delay on Depression Drug
12:59pm, Tuesday, 24'th Aug 2021
FDA delays decision on Axsome Therapeutics' (AXSM) new drug application for AXS-05, a potential treatment for major depressive disorder.
Why Axsome Therapeutics Stock Is Jumping Today
12:15pm, Monday, 23'rd Aug 2021
Investors are happy that the FDA didn't ask for more information to supplement Axsome's regulatory filing for AXS-05.
Axsome Therapeutics Shares Increase Over 20% Pre-Market: Why It Happened
07:53am, Monday, 23'rd Aug 2021
The shares of Axsome Therapeutics Inc (NASDAQ: AXSM) increased by over 20% pre-market. This is why it happened.
